156 results
8-K
EX-99.1
CORT
Corcept Therapeutics Inc
1 May 24
Corcept Therapeutics Announces First Quarter Financial Results
4:09pm
, dazucorilant, miricorilant and our other product candidates, including their clinical attributes, regulatory approvals, mandates, oversight and other
8-K
EX-99.1
q3krwgi ls2
15 Feb 24
Corcept Therapeutics Announces Fourth Quarter Financial Results
4:11pm
8-K
EX-99.1
rnyepoa6y8 9he7k7u
8 Jan 24
Corcept Therapeutics Provides Financial Update
8:06am
8-K
EX-99.1
b53v10f q7ut29jbwma
2 Jan 24
Court Finds Corcept Therapeutics’ Patents Not Infringed
8:06am
8-K
EX-99.1
ungtkn06p
1 Nov 23
Corcept Therapeutics Announces Third Quarter Financial Results
4:13pm
8-K
EX-99.1
76lkz64ui4ffopt8tn9g
2 Aug 23
Corcept Therapeutics Announces Second Quarter Financial Results
4:09pm
8-K
EX-99.1
upi1n
3 May 23
Corcept Therapeutics Announces First Quarter Financial Results
4:13pm
8-K
EX-99.1
uoxhs
3 Nov 22
Corcept Therapeutics Announces Third Quarter Financial Results
4:09pm